Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

921 - 930 of 1049 results found

Flucytosine and its clinical usage

Date
Thursday, April 13, 2023 - 4:00 AM
Description
Flucytosine is an antifungal agent first licensed in the 1970's. However, its clinical value has long been overlooked and its availability across the globe is limited. This review highlights the important clinical and pharmacological aspects of

Frequency of COVID-19 Infection as a Function of Vitamin D Levels

Date
Thursday, April 13, 2023 - 4:00 AM
Description
CONCLUSIONS: Although only a minority of healthy subjects had 25OHD concentrations above 20 ng/mL in spring, an increased risk of subsequent COVID-19 infection was only observed in those with severe 25OHD deficiency (<12 ng/mL).

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses

Date
Wednesday, April 12, 2023 - 4:00 AM
Description
The antibody response to SARS-CoV-2 shows biased immunoglobulin heavy chain variable (IGHV) gene usage, allowing definition of genetic signatures for some classes of neutralizing antibodies. We investigated IGHV gene usage frequencies by sorting

Future lines of research on phase angle: Strengths and limitations

Date
Wednesday, April 12, 2023 - 4:00 AM
Description
Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of